Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio

Table 3

Odds ratios and 95% confidence intervals for the association between metabolic syndrome and various markers.

	Odds ratio (95% CI)
	Model I	Model II	Model III
Adiponectin
1st quartile	1	1	1
2nd quartile	0.59 (0.44–0.79)	0.65 (0.44–0.95)	0.66 (0.44–0.99)
3rd quartile	0.29 (0.21–0.40)	0.58 (0.37–0.89)	0.60 (0.38–0.95)
4th quartile	0.28 (0.20–0.40)	0.34 (0.23–0.51)	0.30 (0.19–0.46)
HOMA-IR
1st quartile	1	1	1
2nd quartile	1.63 (1.11–2.32)	1.62 (1.04–2.52)	1.72 (1.08–2.73)
3rd quartile	2.88 (2.02–4.10)	2.05 (1.33–3.16)	1.83 (1.16–2.88)
4th quartile	7.36 (5.19–10.46)	3.88 (2.52–5.97)	3.82 (2.42–6.04)
A/H ratio
1st quartile	1	1	1
2nd quartile	0.30 (0.22–0.40)	0.53 (0.35–0.80)	0.52 (0.33–0.83)
3rd quartile	0.25 (0.18–0.16)	0.41 (0.28–0.60)	0.43 (0.28–0.66)
4th quartile	0.11 (0.08–0.16)	0.23 (0.15–0.35)	0.25 (0.15–0.40)

CI, confidence interval; HOMA-IR, homeostasis model assessment of insulin resistance; A/H ratio, adiponectin to homeostasis assessment-insulin resistance; MetS, metabolic syndrome; IL-6, interleukin-6.
Model I: adjusted for sex and age.
Model II: adjusted for sex, age, body mass index, smoking status, and low-density lipoprotein cholesterol.
Model III: adjusted for sex, age, body mass index, smoking status, low-density lipoprotein cholesterol, total cholesterol, and high-density lipoprotein cholesterol.